Hypercalcemia associated with cancer

被引:527
作者
Stewart, AF [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Div Endocrinol, Pittsburgh, PA 15213 USA
关键词
D O I
10.1056/NEJMcp042806
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:373 / 379
页数:7
相关论文
共 48 条
[1]   The effect of a single dose of osteoprotegerin in postmenopausal women [J].
Bekker, PJ ;
Holloway, D ;
Nakanishi, A ;
Arrighi, M ;
Leese, PT ;
Dunstan, CR .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :348-360
[2]   A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women [J].
Bekker, PJ ;
Holloway, DL ;
Rasmussen, AS ;
Murphy, R ;
Martin, SW ;
Leese, PT ;
Holmes, GB ;
Dunstan, CR ;
DePaoli, AM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (07) :1059-1066
[3]   Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function [J].
Berenson, JR ;
Rosen, L ;
Vescio, R ;
Lau, HS ;
Woo, M ;
Sioufi, A ;
Kowalski, O ;
Knight, RD ;
Seaman, JJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (04) :285-290
[4]   Clinical practice - Asymptomatic primary hyperparathyroidism [J].
Bilezikian, JP ;
Silverberg, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (17) :1746-1751
[5]   EFFECT OF CALCITONIN AND GLUCOCORTICOIDS IN COMBINATION ON THE HYPERCALCEMIA OF MALIGNANCY [J].
BINSTOCK, ML ;
MUNDY, GR .
ANNALS OF INTERNAL MEDICINE, 1980, 93 (02) :269-272
[6]   A dose-finding study of zoledronate in hypercalcemic cancer patients [J].
Body, JJ ;
Lortholary, A ;
Romieu, G ;
Vigneron, AM ;
Ford, J .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) :1557-1561
[7]   BONE AND RENAL COMPONENTS IN HYPERCALCEMIA OF MALIGNANCY AND RESPONSES TO A SINGLE INFUSION OF CLODRONATE [J].
BONJOUR, JP ;
PHILIPPE, J ;
GUELPA, G ;
BISETTI, A ;
RIZZOLI, R ;
JUNG, A ;
ROSINI, S ;
KANIS, JA .
BONE, 1988, 9 (03) :123-130
[8]  
CARDELLA CJ, 1979, CLIN NEPHROL, V12, P285
[9]   Zoledronic acid [J].
Cheer S.M. ;
Noble S. .
Drugs, 2001, 61 (6) :799-805
[10]  
CLINES GA, 2003, PRIMER METABOLIC BON, P251